ICU Medical (NASDAQ:ICUI) Updates FY 2024 Earnings Guidance

ICU Medical (NASDAQ:ICUI - Get Free Report) updated its FY 2024 earnings guidance on Wednesday. The company provided EPS guidance of 4.400-5.100 for the period, compared to the consensus EPS estimate of 4.730. The company issued revenue guidance of -.

Wall Street Analyst Weigh In

Separately, KeyCorp raised their price target on shares of ICU Medical from $134.00 to $136.00 and gave the stock an overweight rating in a report on Wednesday, February 28th. One equities research analyst has rated the stock with a hold rating and two have issued a buy rating to the stock. According to MarketBeat, ICU Medical has an average rating of Moderate Buy and a consensus price target of $123.00.

ICU Medical Stock Down 1.1 %

NASDAQ ICUI traded down $1.17 during trading on Wednesday, reaching $100.60. The company's stock had a trading volume of 521,388 shares, compared to its average volume of 253,271. The company has a current ratio of 2.53, a quick ratio of 1.06 and a debt-to-equity ratio of 0.74. The stock has a market capitalization of $2.45 billion, a PE ratio of -81.79 and a beta of 0.72. The business has a 50-day moving average price of $100.55 and a 200-day moving average price of $97.11. ICU Medical has a 1-year low of $78.28 and a 1-year high of $212.43.

ICU Medical (NASDAQ:ICUI - Get Free Report) last issued its quarterly earnings data on Tuesday, February 27th. The medical instruments supplier reported $1.24 earnings per share for the quarter, topping analysts' consensus estimates of $0.85 by $0.39. ICU Medical had a negative net margin of 1.31% and a positive return on equity of 6.35%. The business had revenue of $587.86 million during the quarter, compared to analysts' expectations of $564.77 million. On average, research analysts forecast that ICU Medical will post 3.53 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, VP Daniel Woolson sold 791 shares of the business's stock in a transaction on Friday, March 15th. The shares were sold at an average price of $98.27, for a total transaction of $77,731.57. Following the transaction, the vice president now owns 13,980 shares of the company's stock, valued at $1,373,814.60. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In other ICU Medical news, Director George A. Lopez sold 7,978 shares of the business's stock in a transaction on Thursday, March 14th. The shares were sold at an average price of $101.87, for a total value of $812,718.86. Following the sale, the director now owns 877,343 shares of the company's stock, valued at approximately $89,374,931.41. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, VP Daniel Woolson sold 791 shares of the business's stock in a transaction on Friday, March 15th. The shares were sold at an average price of $98.27, for a total transaction of $77,731.57. Following the completion of the sale, the vice president now directly owns 13,980 shares in the company, valued at approximately $1,373,814.60. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 24,262 shares of company stock valued at $2,545,532. 6.70% of the stock is owned by company insiders.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.